621,979 Shares in Centene Corporation $CNC Purchased by PFA Pension Forsikringsaktieselskab

Key Points

• PFA Pension Forsikringsaktieselskab established a new position in Centene (NYSE:CNC) in Q4, buying 621,979 shares worth about $25.63 million and representing roughly 0.13% of the company.
• Centene beat Q1 expectations with EPS $3.37 (vs. $2.23 est.) and revenue of $49.94 billion, spurring several price-target increases, but analyst sentiment remains mixed with a consensus rating of Hold and an average price target near $52.12.

PFA Pension Forsikringsaktieselskab acquired a new position in shares of Centene Corporation (NYSE:CNC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 621,979 shares of the company's stock, valued at approximately $25,632,000. PFA Pension Forsikringsaktieselskab owned about 0.13% of Centene at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UniSuper Management Pty Ltd increased its position in Centene by 66.0% during the third quarter. UniSuper Management Pty Ltd now owns 85,232 shares of the company's stock worth $3,041,000 after purchasing an additional 33,875 shares during the last quarter. Oracle Investment Management Inc. acquired a new stake in Centene during the third quarter worth about $3,936,000. Packer & Co Ltd acquired a new stake in shares of Centene during the third quarter valued at about $50,487,000. First Citizens Bank & Trust Co. increased its position in shares of Centene by 122.5% during the third quarter. First Citizens Bank & Trust Co. now owns 223,157 shares of the company's stock valued at $7,962,000 after acquiring an additional 122,870 shares during the last quarter. Finally, ARGA Investment Management LP acquired a new stake in shares of Centene during the third quarter valued at about $21,485,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Trading Up 0.1%

Shares of CNC stock opened at $53.37 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.12 and a current ratio of 1.12. The stock has a market capitalization of $26.36 billion, a P/E ratio of -4.06, a price-to-earnings-growth ratio of 1.03 and a beta of 1.06. The company has a 50 day moving average price of $38.91 and a 200 day moving average price of $39.49. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $64.15.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, beating analysts' consensus estimates of $2.23 by $1.14. The firm had revenue of $49.94 billion during the quarter, compared to analysts' expectations of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The business's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.90 earnings per share. Equities research analysts predict that Centene Corporation will post 3.46 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Barclays reiterated an "overweight" rating and set a $63.00 price target (up from $54.00) on shares of Centene in a research report on Wednesday. The Goldman Sachs Group reiterated a "sell" rating and set a $40.00 price target on shares of Centene in a research report on Wednesday. Truist Financial lifted their price target on shares of Centene from $49.00 to $58.00 and gave the company a "buy" rating in a research report on Wednesday, April 29th. Wells Fargo & Company lifted their price target on shares of Centene from $44.00 to $56.00 and gave the company an "equal weight" rating in a research report on Friday. Finally, Robert W. Baird lifted their price target on shares of Centene from $36.00 to $37.00 and gave the company a "neutral" rating in a research report on Wednesday, April 15th. Six analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $52.12.

Key Centene News

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Q1 results beat expectations: Centene reported stronger-than-expected EPS and raised its outlook, which supports margin improvement narratives that helped multiple brokers upgrade or re-assess the name. Read More.
• Positive Sentiment: Wall Street bullish notes: Truist reiterated a Buy rating and Cantor Fitzgerald upgraded the stock, signaling investor confidence from some major brokers. Read More. Read More.
• Positive Sentiment: Longer-term recovery thesis boosted: A Seeking Alpha piece highlights promising 2027 turnaround prospects and potential momentum reversal—supportive for investors focused on multi‑year recovery. Read More.
• Positive Sentiment: Wells Fargo raised its price target to $56 while keeping an Equal Weight view, indicating some upside in the broker community even as conviction is measured. Read More.
• Neutral Sentiment: Broker PTs raised but ratings cautious: Deutsche Bank, Mizuho and Morgan Stanley all lifted targets (to $53, $50 and $50 respectively) but maintained Hold/Neutral/Equal Weight stances — a modest vote of confidence that stops short of strong endorsement. Read More. Read More. Read More.
• Neutral Sentiment: Analysts’ opinions remain mixed overall — coverage notes a blend of upgrades and cautious takes, keeping sentiment balanced rather than uniformly positive. Read More.
• Negative Sentiment: Lower consensus price target: A brokerage consensus report shows a $42 average target — well below current levels — which could cap upside if that view gains traction. Read More.
• Negative Sentiment: Execution concerns flagged: A Seeking Alpha commentary warns that further upside will require better operational execution, a caution investors may lean on after recent volatility. Read More.

Centene Company Profile

Centene Corporation NYSE: CNC is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.